A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.
We demonstrate here a rapid alternative method for the production of functional bi-specific antibodies using the mild reducing agent 2-mercaptoethanesulfonic acid sodium salt (MESNA). Following reduction of a mixture of two monoclonal antibodies with MESNA to break inter heavy chain bonds, this solu...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3141073?pdf=render |
id |
doaj-6607d53e3c1e44dda470eaf339710ceb |
---|---|
record_format |
Article |
spelling |
doaj-6607d53e3c1e44dda470eaf339710ceb2020-11-25T02:16:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0167e2253310.1371/journal.pone.0022533A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.Jennifer CarlringEvy De LeenheerAndrew William HeathWe demonstrate here a rapid alternative method for the production of functional bi-specific antibodies using the mild reducing agent 2-mercaptoethanesulfonic acid sodium salt (MESNA). Following reduction of a mixture of two monoclonal antibodies with MESNA to break inter heavy chain bonds, this solution is dialysed under oxidising conditions and antibodies are allowed to reform. During this reaction a mixture of antibodies is formed, including parental antibodies and bi-specific antibody. Bi-specific antibodies are purified over two sequential affinity columns. Following purification, bi-specificity of antibodies is determined in enzyme-linked immunosorbent assays and by flow cytometry. Using this redox method we have been successful in producing hybrid and same-species bi-specific antibodies in a time frame of 6-10 working days, making this production method a time saving alternative to the time-consuming traditional heterohybridoma technology for the production of bi-specific antibodies for use in early pilot studies. The use of both rat and mouse IgG antibodies forming a rat/mouse bi-specific antibody as well as producing a pure mouse bi-specific antibody and a pure rat bi-specific antibody demonstrates the flexibility of this production method.http://europepmc.org/articles/PMC3141073?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jennifer Carlring Evy De Leenheer Andrew William Heath |
spellingShingle |
Jennifer Carlring Evy De Leenheer Andrew William Heath A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies. PLoS ONE |
author_facet |
Jennifer Carlring Evy De Leenheer Andrew William Heath |
author_sort |
Jennifer Carlring |
title |
A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies. |
title_short |
A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies. |
title_full |
A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies. |
title_fullStr |
A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies. |
title_full_unstemmed |
A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies. |
title_sort |
novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2011-01-01 |
description |
We demonstrate here a rapid alternative method for the production of functional bi-specific antibodies using the mild reducing agent 2-mercaptoethanesulfonic acid sodium salt (MESNA). Following reduction of a mixture of two monoclonal antibodies with MESNA to break inter heavy chain bonds, this solution is dialysed under oxidising conditions and antibodies are allowed to reform. During this reaction a mixture of antibodies is formed, including parental antibodies and bi-specific antibody. Bi-specific antibodies are purified over two sequential affinity columns. Following purification, bi-specificity of antibodies is determined in enzyme-linked immunosorbent assays and by flow cytometry. Using this redox method we have been successful in producing hybrid and same-species bi-specific antibodies in a time frame of 6-10 working days, making this production method a time saving alternative to the time-consuming traditional heterohybridoma technology for the production of bi-specific antibodies for use in early pilot studies. The use of both rat and mouse IgG antibodies forming a rat/mouse bi-specific antibody as well as producing a pure mouse bi-specific antibody and a pure rat bi-specific antibody demonstrates the flexibility of this production method. |
url |
http://europepmc.org/articles/PMC3141073?pdf=render |
work_keys_str_mv |
AT jennifercarlring anovelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies AT evydeleenheer anovelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies AT andrewwilliamheath anovelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies AT jennifercarlring novelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies AT evydeleenheer novelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies AT andrewwilliamheath novelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies |
_version_ |
1724893465638076416 |